Catalytic processes are increasingly being explored for targeted drug delivery. Catalysts can be engineered to activate prodrugs specifically at the disease site, minimizing side effects and enhancing therapeutic efficacy. Nanocatalysts, for example, can be designed to release drugs in response to specific physiological conditions like pH changes or the presence of certain enzymes.
